BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27548845)

  • 1. Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.
    Hirt-Minkowski P; Rush DN; Gao A; Hopfer H; Wiebe C; Nickerson PW; Schaub S; Ho J
    Transplantation; 2016 Sep; 100(9):1988-96. PubMed ID: 27548845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft loss.
    Ho J; Wiebe C; Rush DN; Rigatto C; Storsley L; Karpinski M; Gao A; Gibson IW; Nickerson PW
    Transplantation; 2013 Feb; 95(4):595-602. PubMed ID: 23192155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation.
    Blydt-Hansen TD; Gibson IW; Gao A; Dufault B; Ho J
    Transplantation; 2015 Apr; 99(4):797-804. PubMed ID: 25222013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.
    Rabant M; Amrouche L; Lebreton X; Aulagnon F; Benon A; Sauvaget V; Bonifay R; Morin L; Scemla A; Delville M; Martinez F; Timsit MO; Duong Van Huyen JP; Legendre C; Terzi F; Anglicheau D
    J Am Soc Nephrol; 2015 Nov; 26(11):2840-51. PubMed ID: 25948873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 months.
    Ho J; Wiebe C; Gibson IW; Hombach-Klonisch S; Gao A; Rigatto C; Karpinski M; Storsley L; Nickerson PW; Rush DN
    Transplantation; 2014 Jul; 98(1):39-46. PubMed ID: 24646773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary levels of CCL2 and CXCL10 chemokines as potential biomarkers of ongoing pathological processes in kidney allograft: an association with BK virus nephropathy.
    Gniewkiewicz MS; Czerwińska M; Gozdowska J; Czerwińska K; Sadowska A; Dęborska-Materkowska D; Perkowska-Ptasińska A; Kosieradzki M; Durlik M
    Pol Arch Intern Med; 2019 Sep; 129(9):592-597. PubMed ID: 31389404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation.
    Millán O; Budde K; Sommerer C; Aliart I; Rissling O; Bardaji B; Matz M; Zeier M; Silva I; Guirado L; Brunet M
    Br J Clin Pharmacol; 2017 Dec; 83(12):2636-2650. PubMed ID: 28880456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary CXCL10 Measurement in Late Renal Allograft Biopsies Predicts Outcome Even in Histologically Quiescent Patients.
    Handschin J; Wehmeier C; Amico P; Hopfer H; Dickenmann M; Schaub S; Hirt-Minkowski P
    Transplant Proc; 2021 Sep; 53(7):2168-2179. PubMed ID: 34419254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Urinary Matrix Metalloproteinase-7 Detects Underlying Renal Allograft Inflammation and Injury.
    Ho J; Rush DN; Krokhin O; Antonovici M; Gao A; Bestland J; Wiebe C; Hiebert B; Rigatto C; Gibson IW; Wilkins JA; Nickerson PW
    Transplantation; 2016 Mar; 100(3):648-54. PubMed ID: 26906940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Low Urinary CXCL9 and CXCL10 Might Predict Immunological Quiescence in Clinically and Histologically Stable Kidney Recipients.
    Rabant M; Amrouche L; Morin L; Bonifay R; Lebreton X; Aouni L; Benon A; Sauvaget V; Le Vaillant L; Aulagnon F; Sberro R; Snanoudj R; Mejean A; Legendre C; Terzi F; Anglicheau D
    Am J Transplant; 2016 Jun; 16(6):1868-81. PubMed ID: 26694099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Long-term Renal Allograft Outcome By Early Urinary CXCL10 Chemokine Levels.
    Hirt-Minkowski P; Ho J; Gao A; Amico P; Koller MT; Hopfer H; Rush DN; Nickerson PW; Schaub S
    Transplant Direct; 2015 Sep; 1(8):e31. PubMed ID: 27500231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of renal function and urinary biomarker indicators of inflammation on serial kidney biopsies in pediatric kidney transplant recipients with and without rejection.
    Mincham CM; Gibson IW; Sharma A; Wiebe C; Mandal R; Rush D; Nickerson P; Ho J; Wishart DS; Blydt-Hansen TD
    Pediatr Transplant; 2018 Aug; 22(5):e13202. PubMed ID: 29696778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts.
    Ho J; Rush DN; Gibson IW; Karpinski M; Storsley L; Bestland J; Stefura W; HayGlass KT; Nickerson PW
    Transplantation; 2010 Aug; 90(4):394-400. PubMed ID: 20625355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
    Prodjosudjadi W; Daha MR; Gerritsma JS; Florijn KW; Barendregt JN; Bruijn JA; van der Woude FJ; van Es LA
    Nephrol Dial Transplant; 1996 Jun; 11(6):1096-103. PubMed ID: 8671975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Levels and Its Association with Renal Allograft Rejection.
    Raza A; Firasat S; Khaliq S; Khan AR; Mahmood S; Aziz T; Mubarak M; Naqvi SA; Rizvi SA; Abid A
    Immunol Invest; 2017 Apr; 46(3):251-262. PubMed ID: 27960564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of urinary chemokines at 6 months after pediatric kidney transplantation.
    Mockler C; Sharma A; Gibson IW; Gao A; Wong A; Ho J; Blydt-Hansen TD
    Pediatr Transplant; 2018 Aug; 22(5):e13205. PubMed ID: 29733487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term kidney allograft survival in patients with transplant glomerulitis.
    Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
    Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary C‑X‑C motif chemokine 13 is a noninvasive biomarker of antibody‑mediated renal allograft rejection.
    Chen D; Zhang J; Peng W; Weng C; Chen J
    Mol Med Rep; 2018 Aug; 18(2):2399-2406. PubMed ID: 29956754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Urinary Aspartate Aminotransferase in the Late Posttransplant Period Predicts Rapid, Progressive Decline in Kidney Allograft Function.
    Trailin AV; Pleten MV; Ostapenko TI; Iefimenko NF; Nikonenko OS
    Exp Clin Transplant; 2017 Jun; 15(3):267-276. PubMed ID: 28332956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.